Charles Schwab’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Sell |
419,932
-28,315
| -6% | -$187K | ﹤0.01% | 2573 |
|
|
2025
Q1 | $4.1M | Buy |
448,247
+12,903
| +3% | +$118K | ﹤0.01% | 2353 |
|
|
2024
Q4 | $4.57M | Buy |
435,344
+45,182
| +12% | +$474K | ﹤0.01% | 2368 |
|
|
2024
Q3 | $4.66M | Buy |
390,162
+109,359
| +39% | +$1.31M | ﹤0.01% | 2409 |
|
|
2024
Q2 | $1.61M | Buy |
280,803
+95,152
| +51% | +$547K | ﹤0.01% | 2774 |
|
|
2024
Q1 | $965K | Buy |
185,651
+5,105
| +3% | +$26.5K | ﹤0.01% | 2809 |
|
|
2023
Q4 | $951K | Buy |
180,546
+3,198
| +2% | +$16.9K | ﹤0.01% | 2847 |
|
|
2023
Q3 | $585K | Buy |
177,348
+11,719
| +7% | +$38.7K | ﹤0.01% | 2989 |
|
|
2023
Q2 | $479K | Sell |
165,629
-70,716
| -30% | -$204K | ﹤0.01% | 3075 |
|
|
2023
Q1 | $253K | Buy |
236,345
+17,268
| +8% | +$18.5K | ﹤0.01% | 3123 |
|
|
2022
Q4 | $572K | Sell |
219,077
-8,732
| -4% | -$22.8K | ﹤0.01% | 2963 |
|
|
2022
Q3 | $1.6M | Buy |
227,809
+53,959
| +31% | +$378K | ﹤0.01% | 2642 |
|
|
2022
Q2 | $1.19M | Buy |
173,850
+3,681
| +2% | +$25.1K | ﹤0.01% | 2732 |
|
|
2022
Q1 | $2.4M | Buy |
170,169
+4,817
| +3% | +$67.9K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $2.4M | Buy |
165,352
+91,669
| +124% | +$1.33M | ﹤0.01% | 2638 |
|
|
2021
Q3 | $1.04M | Buy |
73,683
+13,602
| +23% | +$193K | ﹤0.01% | 2859 |
|
|
2021
Q2 | $1.06M | Buy |
60,081
+8,662
| +17% | +$153K | ﹤0.01% | 2905 |
|
|
2021
Q1 | $786K | Buy |
+51,419
| New | +$786K | ﹤0.01% | 2928 |
|